Gouws Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Gouws Capital's ABBV Position: Q3 2026 in Review
Gouws Capital held its AbbVie (ABBV) position steady in Q3 2026 at 2,700 shares worth $706K. The position accounts for 0.33% of the portfolio, ranked #31.
Gouws Capital first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 4,121 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Gouws Capital held 2,700 shares of AbbVie worth $706K as of Q3 2026.
- Gouws Capital left its AbbVie share count unchanged in Q3 2026.
- AbbVie made up 0.33% of Gouws Capital's portfolio in Q3 2026, its #31 holding.
- Gouws Capital first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 4,121 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Gouws Capital's 13F filing for Q3 2026, filed 9 Oct 2026.